Federal grants to Partillion Bioscience Corp
Partillion Bioscience Corp in Los Angeles, California received $5.3 million in federal grants from fiscal 2021 to 2025, across 8 awards. Its largest program was Biomedical Research and Research Training, with $3.8 million. In fiscal 2025 it was awarded $1.0 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$5.3 million
- Awards8
- Awarded in FY 2025$1.0 million
- Largest award$1.5 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 4 | $1.1 million |
| FY 2022 | 0 | $0 |
| FY 2023 | 3 | $1.8 million |
| FY 2024 | 2 | $1.5 million |
| FY 2025 | 1 | $1.0 million |
Programs that fund Partillion Bioscience Corp
| Program | Awards | Amount |
|---|---|---|
| Biomedical Research and Research Training | 5 | $3.8 million |
| Allergy and Infectious Diseases Research | 2 | $1.3 million |
| Engineering | 1 | $255,916 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 7 | $5.1 million |
| National Science Foundation | 1 | $255,916 |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Linking antibody sequences to function at the single-cell level using nanovial technology - abstract monoclonal antibody therapies now account for the majority of blockbuster drugs and the number and breadth of diseases tackled by this therapeutic modality are expected to rapidly grow in the coming | Biomedical Research and Research Training | September 13, 2023 | $1.5 million |
| Hydrogel microparticle technology for high-throughout screening of chimeric antigen receptor-t cells based on single cell effector function - abstract engineered cell therapies are becoming a pillar of medicine, along with molecular and genetic interventions. In particular, chimeric antigen receptor | Biomedical Research and Research Training | September 6, 2023 | $1.5 million |
| Scaling function-first antibody discovery leveraging memory b cells - abstract monoclonal antibody therapies represent a significant portion of blockbuster drugs, with their applications expected to expand dramatically in the coming decade. However, current antibody discovery methodologies often req | Allergy and Infectious Diseases Research | April 1, 2025 | $1.0 million |
| High-throughput antibody discovery directly from b cells using nanovial technology - abstract six out of ten top-grossing drugs in 2019 were monoclonal antibodies (MABS), up from zero in 2010. By enabling highly-targeted therapies with enhanced efficacy and reduced side effects, mabs have provided e | Biomedical Research and Research Training | September 16, 2021 | $355,051 |
| Multiplexed analysis of secreted proteins from single-cells using high dynamic range nanovials - abstract cellular secretions make up a significant portion of the proteome, playing a crucial role in governing a range of bodily functions – in particular immunity. Despite their significance, the study | Allergy and Infectious Diseases Research | July 18, 2023 | $275,489 |
| Sbir phase i: microparticle reagents for clonal selection of producer cell lines | Engineering | June 16, 2021 | $255,916 |
| Magnetic sorting and selection of producer cells based on secretion and growth using nanovial technology - abstract cell secretions are fundamental to biological processes, biotechnology, and cell therapies, however, approaches to rapidly separate out viable cell populations based on secretions are | Biomedical Research and Research Training | May 31, 2021 | $236,407 |
| Nanovials for high-throughput analysis and selection of single cells based on secreted bio-products - abstract cell secretions are fundamental to biological processes, biotechnology, and cell therapies. The ability to analyze and select out single cells based on secretions is particularly critical f | Biomedical Research and Research Training | April 28, 2021 | $219,679 |
Questions people ask
How much federal grant money does Partillion Bioscience Corp get?
$5.3 million in 8 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Partillion Bioscience Corp the most?
The Department of Health and Human Services, with $5.1 million in 7 awards. The National Science Foundation follow.
What is Partillion Bioscience Corp's largest federal grant?
$1.5 million under Biomedical Research and Research Training, with its first action in the period on September 13, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Partillion Bioscience Corp?
Its largest are Biomedical Research and Research Training, Allergy and Infectious Diseases Research and Engineering.
Other grant recipients in Los Angeles
- Los Angeles County Metropolitan Transportation Authority
- University of California, Los Angeles
- University of Southern California
- County of Los Angeles
- Department of Airports of the City of Los Angeles
- The Workforce Investment Board of the City of Los Angeles
- Cedars-Sinai Medical Center
- Housing Authority of the City of Los Angeles
Largest federal grant recipients in California · Federal grants in California